 PETACH TIKVA, Israel--BUSINESS WIRE--- CANF--Can-Fite BioPharma Ltd. NYSE American: CANF TASE:CFBI, a biotechnology company advancing a pipeline of proprietary small molecule drugs that address inflammatory, cancer and liver diseases, today announced the Chinese National Intellectual Property Administration has issued a Notice of Allowance for its patent titled An A3 Adenosine Receptor Ligand For Use In Treating Ectopic Fat Accumulation. This patent addresses the use of the A3 Adenosine Recepto 